8-K ·Filed Feb 26, 2026

VTRS

Viatris Inc
MIXED
Impact 7/10
Horizonweeks Processed7mo ago SEC0001792044-26-000010
Killer combo: Earnings + restructuring announcement
Actionable Insight ◆ Mixed

The stock may react positively to the 2026 growth guidance and cost savings plan, but investors should monitor the execution of the restructuring, resolution of the India manufacturing issues, and whether the recent quarterly revenue improvement can be sustained to reverse the full-year decline trend.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
VTRS ▲ +8.86% at T+60d
NEUTRAL call ✓ call won +8.86% · α vs SPY +1.11% · entry $15.12 → $16.46
Entry anchored
Feb 25, 03:59 PM ET
via exchange tick
T+1d
-2.10%
call -2.10% · α -1.65%
$14.80
settled 7mo ago
T+5d
-4.72%
call -4.72% · α -3.59%
$14.41
settled 7mo ago
T+20d
-11.58%
call -11.58% · α -5.18%
$13.37
settled 6mo ago
T+60d
+8.86%
call +8.86% · α +1.11%
$16.46
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Viatris reported mixed financial results for 2025, with full-year revenue declining 3% YoY but fourth-quarter revenue growing 5% YoY. The company announced a major restructuring expected to incur $700M-$850M in charges to achieve $650M in cost savings, while also revealing a fire at its Nashik, India manufacturing facility. Despite the operational challenges, management provided 2026 guidance projecting revenue growth to $14.45B-$14.95B and positioned the company for a turnaround.

Key Financial Metrics

Revenue
$14.3B
-3.0% YoY
Adj. EPS
$2.35
GAAP: $-3.00
Guidance
$14,450 - $14,950
provided
Free Cash Flow
$1.9B
Gross Margin
35.1%

Key Facts

  • Full-year 2025 revenue declined 3% YoY to $14.3B, with generics revenue down 8% and brands revenue flat
  • Fourth-quarter revenue grew 5% YoY to $3.7B, showing recent improvement
  • Company announced restructuring with $700M-$850M in charges to achieve $650M in cost savings
  • Fire at Nashik, India manufacturing facility temporarily suspended operations with expected resumption in April 2026
  • 2026 guidance projects revenue of $14.45B-$14.95B and adjusted EPS of $2.33-$2.47
  • Adjusted EPS declined 11% YoY to $2.35 in 2025

Financial Impact

Restructuring charges of $700M-$850M expected to yield $650M in cost savings; 2026 revenue guidance of $14.45B-$14.95B represents 1-5% growth over 2025

revenueepsmarginscashFlowrestructuring costs

Segment Breakdown

SegmentRevenueGrowth
Brands$9.2B-0.2%
Generics$5.1B-7.7%

Risk Factors

  • Execution risk on the major restructuring plan
  • Ongoing manufacturing issues at India facilities impacting supply
  • Declining generics business (-8% YoY) and flat brands revenue
  • High debt levels with $12.5B in long-term debt

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001792044-26-000010
Document: vtrs-20260223.htm0001792044-26-000010
Document: 0001792044-26-000010-index-headers.html0001792044-26-000010
Document: 0001792044-26-000010-index.html0001792044-26-000010
Document: 0001792044-26-000010.txt0001792044-26-000010
12 reports for VTRS
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +17.24%May 4, 2026
Filters
Rows
Reports for VTRS — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$16.29 $16.94▲ +3.99%▲ +3.39%$17.60 (+8.04%)
Jun 25, 2026
14w ago
144
NEUTRAL ★ 3/10
$16.33 $17.28▲ +5.82%▲ +4.56%$17.60 (+7.78%)
Jun 18, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$15.38 $17.29▲ +12.42%▲ +12.57%$17.60 (+14.43%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$16.04 $16.31▲ +1.68%▲ +1.48%$17.60 (+9.73%)
May 13, 2026
20w ago
Court Ruling
BULLISH ★ 7/10
$17.37 $16.31▼ −6.10%▼ −5.49%$17.60 (+1.32%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$17.39 $15.56▼ −10.52%▼ −13.66%$17.60 (+1.21%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$15.52 $15.69▲ +1.10%▼ −3.86%$17.60 (+13.40%)
May 4, 2026
21w ago
Court Ruling
NEUTRAL ★ 2/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
May 4, 2026
21w ago
Court Ruling
BULLISH ★ 4/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
Apr 13, 2026
24w ago
Court Ruling
MIXED ★ 6/10
$13.83 $16.92▲ +22.34%▲ +14.59%$17.60 (+27.26%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access